413 related articles for article (PubMed ID: 18292975)
1. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.
Dawson-Hughes B; Tosteson AN; Melton LJ; Baim S; Favus MJ; Khosla S; Lindsay RL;
Osteoporos Int; 2008 Apr; 19(4):449-58. PubMed ID: 18292975
[TBL] [Abstract][Full Text] [Related]
2. Cost-effective osteoporosis treatment thresholds: the United States perspective.
Tosteson AN; Melton LJ; Dawson-Hughes B; Baim S; Favus MJ; Khosla S; Lindsay RL;
Osteoporos Int; 2008 Apr; 19(4):437-47. PubMed ID: 18292976
[TBL] [Abstract][Full Text] [Related]
3. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
Bolland MJ; Grey A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1856-60. PubMed ID: 20147581
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
Arch Osteoporos; 2013; 8(1):136. PubMed ID: 24113837
[TBL] [Abstract][Full Text] [Related]
5. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
6. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
[TBL] [Abstract][Full Text] [Related]
7. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
Stevenson M; Davis S; Lloyd-Jones M; Beverley C
Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
[TBL] [Abstract][Full Text] [Related]
9. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study.
Chang KP; Center JR; Nguyen TV; Eisman JA
J Bone Miner Res; 2004 Apr; 19(4):532-6. PubMed ID: 15005838
[TBL] [Abstract][Full Text] [Related]
10. Updated fracture incidence rates for the US version of FRAX.
Ettinger B; Black DM; Dawson-Hughes B; Pressman AR; Melton LJ
Osteoporos Int; 2010 Jan; 21(1):25-33. PubMed ID: 19705048
[TBL] [Abstract][Full Text] [Related]
11. Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men.
Haentjens P; Johnell O; Kanis JA; Bouillon R; Cooper C; Lamraski G; Vanderschueren D; Kaufman JM; Boonen S;
J Bone Miner Res; 2004 Dec; 19(12):1933-44. PubMed ID: 15537435
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
[TBL] [Abstract][Full Text] [Related]
13. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women.
Lippuner K; Johansson H; Kanis JA; Rizzoli R
Osteoporos Int; 2009 Jul; 20(7):1131-40. PubMed ID: 18974918
[TBL] [Abstract][Full Text] [Related]
14. Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance.
Looker AC; Dawson-Hughes B; Tosteson AN; Johansson H; Kanis JA; Melton LJ
Osteoporos Int; 2011 Feb; 22(2):541-9. PubMed ID: 20480142
[TBL] [Abstract][Full Text] [Related]
15. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
Siris ES; Brenneman SK; Barrett-Connor E; Miller PD; Sajjan S; Berger ML; Chen YT
Osteoporos Int; 2006; 17(4):565-74. PubMed ID: 16392027
[TBL] [Abstract][Full Text] [Related]
16. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
17. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs.
Sander B; Elliot-Gibson V; Beaton DE; Bogoch ER; Maetzel A
J Bone Joint Surg Am; 2008 Jun; 90(6):1197-205. PubMed ID: 18519311
[TBL] [Abstract][Full Text] [Related]
18. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.
Ray NF; Chan JK; Thamer M; Melton LJ
J Bone Miner Res; 1997 Jan; 12(1):24-35. PubMed ID: 9240722
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis in the European Union: a compendium of country-specific reports.
Svedbom A; Hernlund E; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA;
Arch Osteoporos; 2013; 8(1):137. PubMed ID: 24113838
[TBL] [Abstract][Full Text] [Related]
20. Cost-effective osteoporosis treatment thresholds in Greece.
Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
